Cargando…
Toward a Combination of Biomarkers for Molecular Characterization of Multiple Sclerosis
Multiple sclerosis (MS) is an autoimmune disease affecting the central nervous system associated with chronic inflammation, demyelination, and axonal damage. MS is a highly heterogeneous disease that leads to discrepancies regarding the clinical appearance, progression, and therapy response of patie...
Autores principales: | Birmpili, Dafni, Charmarke Askar, Imane, Pham-Van, Lucas Dinh, Kuntzel, Thomas, Spenlé, Caroline, Riou, Aurélien, Bagnard, Dominique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695566/ https://www.ncbi.nlm.nih.gov/pubmed/36430480 http://dx.doi.org/10.3390/ijms232214000 |
Ejemplares similares
-
Implication of the Transmembrane Domain in the Interleukin 10 Receptor Platform Oligomerisation
por: Kuntzel, Thomas, et al.
Publicado: (2023) -
The Translatability of Multiple Sclerosis Animal Models for Biomarkers Discovery and Their Clinical Use
por: Birmpili, Dafni, et al.
Publicado: (2022) -
Manipulating Macrophage/Microglia Polarization to Treat Glioblastoma or Multiple Sclerosis
por: Kuntzel, Thomas, et al.
Publicado: (2022) -
Disruption of Sema3A/Plexin‐A1 inhibitory signalling in oligodendrocytes as a therapeutic strategy to promote remyelination
por: Binamé, Fabien, et al.
Publicado: (2019) -
Functionalized Tobacco Mosaic Virus Coat Protein Monomers and Oligomers as Nanocarriers for Anti-Cancer Peptides
por: Gamper, Coralie, et al.
Publicado: (2019)